EUVIMEDScopri EUVIMED
StudienprotokollOpen access · CC BY-NC 4.0

Protocol liver biopsy predicts graft survival after liver transplantation

Ville H Liukkonen iD, Arno J Nordin iD, Martti A Färkkilä iD, Tuomas K Mirtti iD, Johanna T Arola iD, Fredrik O Åberg iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15286 ↗

At a glance

Studienprotokoll in Clinical Transplantation, 2024. Written by Ville H Liukkonen and 5 co-authors. Institution: Gastroenterology, North Karelia Central Hospital, Joensuu, Finland. Major MEDLINE topics: Liver Transplantation. Cited 5 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

The use of protocol liver biopsy to monitor liver allograft status remains controversial. There is limited data from modern transplantation populations that includes protocol biopsies to evaluate its value in predicting clinical outcomes.

Methods

All protocol liver biopsies were identified from 875 patients who underwent liver transplantation at Helsinki University Hospital between 2000 and 2019. Each histologic component was analyzed for its ability to predict long‐term outcomes, especially graft survival. We determined the frequency of significant biopsy findings based on the Banff working group definition. Liver function tests (LFTs) and clinical markers were evaluated for their ability to predict significant biopsy findings.

Results

In total, 867 protocol liver biopsies were analyzed. Significant findings were identified in 20.1% of the biopsies. In the first protocol biopsy, steatohepatitis (hazard ratio [HR] 3.504, p = .03) and moderate or severe congestion (HR 3.338, p = .04) predicted graft loss. The presence of cholangitis (HR 2.563, p = .04), necrosis (HR 7.635, p < .001), mild congestion (HR 4.291, p = .009), and significant biopsy finding (HR 2.540, p = .02) predicted inferior death‐censored graft survival. While the degree of elevation of LFTs was positively associated with significant biopsy findings, the discrimination was poor (AUC .572–.622). Combined LFTs and clinical risk factors remained suboptimal for discriminating significant biopsy findings (AUC .696).

Conclusions

Our findings support the use of protocol liver biopsies after liver transplantation since they frequently revealed changes associated with long‐term outcomes, even when LFTs were normal.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationHumansGraft SurvivalTransplantation, HomologousLiverBiopsyGraft Rejection

Author keywords

graft survivalliver transplantationprotocol liver biopsy

Authors and institutions

  • Gastroenterology, North Karelia Central Hospital, Joensuu, Finland.
  • Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Transplantation and liver surgery, Helsinki University Hospital, Helsinki, Finland.
  • Department of Pathology, Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.

ORCID profiles: Ville H Liukkonen, Arno J Nordin, Martti A Färkkilä, Tuomas K Mirtti, Johanna T Arola, Fredrik O Åberg

Cite

APA

Liukkonen, V. H., Nordin, A. J., Färkkilä, M. A., Mirtti, T. K., Arola, J. T., & Åberg, F. O. (2024). Protocol liver biopsy predicts graft survival after liver transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15286

Vancouver

Liukkonen VH, Nordin AJ, Färkkilä MA, Mirtti TK, Arola JT, Åberg FO. Protocol liver biopsy predicts graft survival after liver transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15286

BibTeX
@article{Liukkonen2024,
  author = {Liukkonen, Ville H and Nordin, Arno J and Färkkilä, Martti A and Mirtti, Tuomas K and Arola, Johanna T and Åberg, Fredrik O},
  title = {Protocol liver biopsy predicts graft survival after liver transplantation},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15286}
}
Start for free →